These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 21683818)

  • 1. Anticoagulation for atrial fibrillation: underuse?
    Pechlaner C
    Am J Med; 2011 Jul; 124(7):e11; author reply e13. PubMed ID: 21683818
    [No Abstract]   [Full Text] [Related]  

  • 2. The need for new oral anticoagulants in clinical practice.
    Hylek EM
    J Cardiovasc Med (Hagerstown); 2009 Aug; 10(8):605-9. PubMed ID: 19571764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antithrombotic therapy in atrial fibrillation with ximelagatran: can it be an alternative to warfarin?].
    Selçuk H; Selçuk MT; Maden O
    Anadolu Kardiyol Derg; 2007 Mar; 7(1):54-8. PubMed ID: 17347079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence-based emergency medicine. Anticoagulation or antiplatelet therapy for non-rheumatic atrial fibrillation and flutter.
    Diner BM
    Ann Emerg Med; 2003 Jan; 41(1):141-3. PubMed ID: 12514695
    [No Abstract]   [Full Text] [Related]  

  • 5. [Oral anticoagulation for prevention of thromboembolism in non-rheumatic atrial fibrillation: indications, effectiveness and risk].
    Kottkamp H; Willems S; Hindricks G; Chen X; Haverkamp W; Hasfeld M; Borggrefe M; Breithardt G
    Z Kardiol; 1993 Nov; 82(11):667-73. PubMed ID: 8291287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The international normalized ratio range of 2.0 to 3.0 remains appropriate for atrial fibrillation.
    Singer DE; Fang MC; Go AS
    Arch Intern Med; 2009 Nov; 169(21):2032; author reply 2033. PubMed ID: 19933969
    [No Abstract]   [Full Text] [Related]  

  • 7. [Anticoagulation in atrial fibrillation].
    Binggeli C; Brunckhorst CB
    Herz; 2008 Feb; 33(1):13-9. PubMed ID: 18273573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contra: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Caveats regarding use of oral anticoagulant therapy among elderly patients with atrial fibrillation.
    Hylek EM
    Thromb Haemost; 2008 Jul; 100(1):16-7. PubMed ID: 18612532
    [No Abstract]   [Full Text] [Related]  

  • 9. [Reasons for underuse of oral anticoagulation in atrial fibrillation-associated stroke: prospective study of German stroke patients].
    Reicke B; Masuhr F; Weih M
    Fortschr Neurol Psychiatr; 2008 Jul; 76(7):391-5. PubMed ID: 18604772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticoagulation in atrial fibrillation and flutter.
    Scholten MF; Thornton AS; Mekel JM; Koudstaal PJ; Jordaens LJ
    Europace; 2005 Sep; 7(5):492-9. PubMed ID: 16087116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dabigatran: safer, more effective and easier to use than warfarin.
    Cardiovasc J Afr; 2009; 20(5):311-2. PubMed ID: 19907807
    [No Abstract]   [Full Text] [Related]  

  • 12. Female gender is a risk factor for stroke and thromboembolism in atrial fibrillation patients.
    Lane DA; Lip GY
    Thromb Haemost; 2009 May; 101(5):802-5. PubMed ID: 19404530
    [No Abstract]   [Full Text] [Related]  

  • 13. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter.
    Cairns JA; Connolly S; McMurtry S; Stephenson M; Talajic M;
    Can J Cardiol; 2011; 27(1):74-90. PubMed ID: 21329865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Newer oral anticoagulants should be used as first-line agents to prevent thromboembolism in patients with atrial fibrillation and risk factors for stroke or thromboembolism.
    Granger CB; Armaganijan LV
    Circulation; 2012 Jan; 125(1):159-64; discussion 164. PubMed ID: 22215890
    [No Abstract]   [Full Text] [Related]  

  • 15. Do population studies confirm the benefit of oral anticoagulation in atrial fibrillation demonstrated in clinical trials?
    Willems R; Exner DV
    J Interv Card Electrophysiol; 2004; 10 Suppl 1():9-16. PubMed ID: 14739734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation: ready for the prime time?
    Tzikas A; Freixa X; Ibrahim R
    Expert Rev Cardiovasc Ther; 2013 Dec; 11(12):1587-9. PubMed ID: 24215187
    [No Abstract]   [Full Text] [Related]  

  • 17. Ablation for atrial fibrillation: can we decrease thromboembolism without increasing the risk for bleeding?
    Asirvatham SJ
    Circulation; 2007 Nov; 116(22):2517-9. PubMed ID: 18040036
    [No Abstract]   [Full Text] [Related]  

  • 18. New-onset atrial fibrillation and warfarin initiation: high risk periods and implications for new antithrombotic drugs.
    Garcia DA; Lopes RD; Hylek EM
    Thromb Haemost; 2010 Dec; 104(6):1099-105. PubMed ID: 20886196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New oral anticoagulants in atrial fibrillation.
    Turpie AG
    Eur Heart J; 2008 Jan; 29(2):155-65. PubMed ID: 18096568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Drug therapy in atrial fibrillation].
    Schuchert A
    Herzschrittmacherther Elektrophysiol; 2014 Mar; 25(1):1-2. PubMed ID: 24525719
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.